SSAB (OTCMKTS:SSAAY – Get Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 199 shares, an increase of 2,387.5% from the August 15th total of 8 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 1,113 shares, the days-to-cover ratio is presently 0.2 days.
SSAB Price Performance
SSAB stock opened at $5.44 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.43 and a quick ratio of 1.37. The company has a market capitalization of $10.84 billion, a PE ratio of 18.13 and a beta of 1.42. SSAB has a one year low of $2.86 and a one year high of $5.74. The business has a 50 day simple moving average of $5.31 and a 200 day simple moving average of $4.85.
SSAB (OTCMKTS:SSAAY – Get Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The basic materials company reported $0.11 earnings per share for the quarter. SSAB had a return on equity of 8.18% and a net margin of 5.73%.The firm had revenue of $2.94 billion for the quarter. On average, sell-side analysts forecast that SSAB will post 0.39 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on SSAAY
About SSAB
SSAB AB is a Sweden-based steel company that develops and produces high-strength, special, and conventional steel products for industrial customers worldwide. Its offerings include advanced high-strength steels, wear-resistant steels, quenched and tempered steels, structural steels, and color-coated products used in vehicles, construction equipment, infrastructure, energy, and other industrial applications.
The company operates through business areas including SSAB Special Steels, SSAB Europe, and SSAB Americas.
See Also
- Five stocks we like better than SSAB
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for SSAB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SSAB and related companies with MarketBeat.com's FREE daily email newsletter.
